Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced / Metastatic Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01905228
What this trial is testing

Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm

Who this might be right for
Solid TumorsGlioblastoma
Incuron 83
Very early researchLooking for participantsNCT06937567
What this trial is testing

CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors

Who this might be right for
Biliary Tract CancerColorectal CarcinomaGastric Cancer, Metastatic+2 more
Zhejiang University 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299
What this trial is testing

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more
M.D. Anderson Cancer Center 35
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Early research (Phase 1)UnknownNCT03669601
What this trial is testing

AZD6738 & Gemcitabine as Combination Therapy

Who this might be right for
Cancer
CCTU- Cancer Theme 55
Early research (Phase 1)Study completedNCT00375245
What this trial is testing

Rapamycin With Grapefruit Juice for Advanced Malignancies

Who this might be right for
TumorsNeoplasm Metastasis
University of Chicago 41
Testing effectiveness (Phase 2)UnknownNCT03864575
What this trial is testing

An Open Label Phase II Study Combining Nivolumab and Celecoxib in Patients With Advanced " Cold " Solid Tumors

Who this might be right for
Metastatic Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 68
Testing effectiveness (Phase 2)Study completedNCT00831636
What this trial is testing

A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Clavis Pharma 28
Testing effectiveness (Phase 2)UnknownNCT05105464
What this trial is testing

Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Unresectable Carcinoma
Shanghai Runshi Pharmaceutical Technology Co., Ltd 97
Testing effectiveness (Phase 2)Looking for participantsNCT07148128
What this trial is testing

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

Who this might be right for
Advanced or Metastatic KRAS-mutant Tumor in Pancreatic AdenocarcinomaAdvanced or Metastatic KRAS-mutant Tumor in Colorectal CancerAdvanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer+2 more
Auricula Biosciences Inc.
Early research (Phase 1)UnknownNCT03847168
What this trial is testing

KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer

Who this might be right for
Breast CancerGastric/Gastroesophageal Junction Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 22
Testing effectiveness (Phase 2)Looking for participantsNCT06311214
What this trial is testing

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
National Cancer Institute (NCI) 500
Early research (Phase 1)Ended earlyNCT05827614
What this trial is testing

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Who this might be right for
Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more
Boundless Bio, Inc. 85
Testing effectiveness (Phase 2)Looking for participantsNCT06031584
What this trial is testing

BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal Tumors

Who this might be right for
Her2-positive/Low-expression Urinary and Digestive Tract Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 42
Early research (Phase 1)Ended earlyNCT04671849
What this trial is testing

An Open Label, Multi-center, Phase I Clinical Study to Evaluate the Safety, Effectiveness and Pharmacokinetic Characteristics of SIM1803-1A in Patients With Locally Advanced/Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Mutations.

Who this might be right for
Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion
Jiangsu Simcere Pharmaceutical Co., Ltd. 24
Early research (Phase 1)WithdrawnNCT05644626
What this trial is testing

Safety, Pharmacokinetics and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab in Participants With Solid Tumors in Chinese Participants

Who this might be right for
Solid Tumors
BeiGene
Early research (Phase 1)Study completedNCT00329004
What this trial is testing

A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
CancerTumor
Bristol-Myers Squibb 89
Early research (Phase 1)Not Yet RecruitingNCT07827144
What this trial is testing

Test How Well Different Doses of BI 4060107 Are Tolerated by People With Advanced Cancer (Solid Tumours)

Who this might be right for
Solid Tumours
AIMEDBIO 90
Early research (Phase 1)Study completedNCT00255658
What this trial is testing

Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 40
Early research (Phase 1)Ended earlyNCT04242147
What this trial is testing

Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Solid Tumor
Kadmon, a Sanofi Company 45
Next Page
110